Periodontal treatment impacts risk factors for cardiovascular disease
The majority of dental health-care professionals, and many in the lay public, recognize some level of association between the mouth and the body. Most prominently understood is the impact periodontitis has on a variety of systemic diseases and conditions. Less widely accepted, however, is the positi...
Saved in:
Published in | Dental Economics Vol. 110; no. 6; p. 1 |
---|---|
Main Author | |
Format | Trade Publication Article |
Language | English |
Published |
Tulsa
Endeavor Business Media
01.06.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The majority of dental health-care professionals, and many in the lay public, recognize some level of association between the mouth and the body. Most prominently understood is the impact periodontitis has on a variety of systemic diseases and conditions. Less widely accepted, however, is the positive impact periodontal therapy has on cardiovascular disease (CVD) and its risk factors--despite the number of studies substantiating this effect. One of the primary risk factors for CVD is hyperlipidemia, which is characterized by elevated levels of a variety of lipids including total cholesterol, triglycerides, LDL cholesterol, and decreased levels of HDL. Literature demonstrates a bidirectional relationship between periodontal disease and hyperlipidemia, which are both chronic inflammatory diseases with complex etiologies. Studies as far back as 2010 demonstrated a positive effect of statin treatment on periodontal attachment loss. Conversely, a variety of studies demonstrate improvement in serum lipid levels in patients with hyperlipidemia following periodontal treatment. |
---|---|
ISSN: | 0011-8583 |